Skip to content
[P]pubcas
🌐 English
EnglishEnglish简体中文Simplified Chinese繁體中文Traditional ChineseEspañolSpanishFrançaisFrenchDeutschGermanPortuguêsPortugueseРусскийRussianالعربيةArabic日本語Japanese한국어KoreanItalianoItalianNederlandsDutchPolskiPolishTürkçeTurkishTiếng ViệtVietnameseไทยThaiBahasa IndonesiaIndonesianBahasa MelayuMalayहिन्दीHindiবাংলাBengaliاردوUrduفارسیPersianעבריתHebrewУкраїнськаUkrainianRomânăRomanianČeštinaCzechSlovenčinaSlovakMagyarHungarianΕλληνικάGreekБългарскиBulgarianSvenskaSwedishDanskDanishNorsk bokmålNorwegian BokmalSuomiFinnishEestiEstonianLatviešuLatvianLietuviųLithuanianSlovenščinaSlovenianHrvatskiCroatianСрпскиSerbianBosanskiBosnianМакедонскиMacedonianShqipAlbanianAzərbaycanAzerbaijaniქართულიGeorgianՀայերենArmenianҚазақшаKazakhOʻzbekchaUzbekКыргызчаKyrgyzТоҷикӣTajikTürkmençeTurkmenМонголMongolianनेपालीNepaliසිංහලSinhalaதமிழ்TamilతెలుగుTeluguमराठीMarathiગુજરાતીGujaratiಕನ್ನಡKannadaമലയാളംMalayalamਪੰਜਾਬੀPunjabiଓଡ଼ିଆOdiaঅসমীয়াAssameseမြန်မာBurmeseខ្មែរKhmerລາວLaoFilipinoFilipinoKiswahiliSwahiliAfrikaansAfrikaansአማርኛAmharicHausaHausaYorùbáYorubaIgboIgboisiZuluZuluisiXhosaXhosaSoomaaliSomaliMalagasyMalagasyKinyarwandaKinyarwandaChiShonaShonaChichewaChichewaپښتوPashtoسنڌيSindhiKurdîKurdish KurmanjiБеларускаяBelarusianÍslenskaIcelandicGaeilgeIrishCymraegWelshMaltiMalteseEuskaraBasqueCatalàCatalanGalegoGalicianLëtzebuergeschLuxembourgishBasa JawaJavaneseBasa SundaSundaneseKreyòl ayisyenHaitian CreoleMāoriMaoriGagana SamoaSamoanLatinaLatinEsperantoEsperanto
Independent chemical reference Compare
Chemical substance record

Ritlecitinib

1792180-81-4C15H19N5O285.351 g/mol

A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine substituted at position 4 by a [(3R,6S)-6-methyl-1-(prop-2-enoyl)piperidin-3-yl]amino group. It is a dual inhibitor of Janus kinase 3 and the TEC family of tyrosine kinases. — ChEBI

Quick answers Safety references

Quick answers about Ritlecitinib

Identity · formula · mass

What is Ritlecitinib, CAS 1792180-81-4?

Ritlecitinib is the substance linked to CAS 1792180-81-4 in ChEBI entry CHEBI:229233. The reported formula is C15H19N5O. Confirm the structural identifiers when distinguishing salts, hydrates, isomers or isotopically labelled materials.

Source ↗

What is the molar mass of Ritlecitinib?

The ChEBI-reported molar mass is 285.351 g/mol for formula C15H19N5O. Its source-reported monoisotopic mass is 285.15896 Da; that uses a specific isotope composition and is a different quantity.

Source ↗

Which PubChem properties are available for Ritlecitinib?

CID 118115473 is connected to this record by an exact InChIKey match. PubChem reports exact mass 285.15896025 Da. computed XLogP 2.1. Values and source conventions are shown separately in the property tables below.

Source ↗

Identity & molecular properties

Source-linked values
CAS number1792180-81-4ChEBI ↗
Chemical formulaC15H19N5OChEBI ↗
Molar mass285.351 g/molChEBI ↗
Monoisotopic mass285.15896 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:229233ChEBI ↗

PubChem molecular properties

PubChem
Molar mass285.34 g/molPubChem ↗
Exact mass285.15896025 DaPubChem ↗
Computed XLogP2.1PubChem ↗
Topological polar surface area (Ų)73.9PubChem ↗
H-bond donors2PubChem ↗
H-bond acceptors4PubChem ↗
Rotatable bonds3PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
ritlecitinib
1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one
CBRJPFGIXUFMTM-WDEREUQCSA-N
C=CC(=O)N1C[C@H](Nc2ncnc3nccc23)CC[C@@H]1C
InChI=1S/C15H19N5O/c1-3-13(21)20-8-11(5-4-10(20)2)19-15-12-6-7-16-14(12)17-9-18-15/h3,6-7,9-11H,1,4-5,8H2,2H3,(H2,16,17,18,19)/t10-,11+/m0/s1

Names & synonyms

1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-oneritlecitinibum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

renoprotective agentanti-inflammatory drughypoglycemic agentantineoplastic agentimmunosuppressive agentantirheumatic drugdermatologic druganti-inflammatory agentEC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00350446 mol

Uses 285.351 g/mol from ChEBI; basis: the substance and formula represented in this record. No purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 15 atoms
63.14%
N
Nitrogen · 5 atoms
24.54%
H
Hydrogen · 19 atoms
6.71%
O
Oxygen · 1 atom
5.61%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:229233

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 118115473 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.